BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12682407)

  • 21. Poisoning of human DNA topoisomerase I by ecteinascidin 743, an anticancer drug that selectively alkylates DNA in the minor groove.
    Takebayashi Y; Pourquier P; Yoshida A; Kohlhagen G; Pommier Y
    Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7196-201. PubMed ID: 10377391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The unique biological features of the marine product Yondelis (ET-743, trabectedin) are shared by its analog ET-637, which lacks the C ring.
    Erba E; Cavallaro E; Damia G; Mantovani R; Di Silvio A; Di Francesco AM; Riccardi R; Cuevas C; Faircloth GT; D'Incalci M
    Oncol Res; 2004; 14(11-12):579-87. PubMed ID: 15666999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trabectedin: Ecteinascidin 743, Ecteinascidin-743, ET 743, ET-743, NSC 684766.
    Drugs R D; 2006; 7(5):317-28. PubMed ID: 16922593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies directed to the total synthesis of ET 743 and analogues thereof: an expeditious route to the ABFGH subunit.
    Zhou B; Guo J; Danishefsky SJ
    Org Lett; 2002 Jan; 4(1):43-6. PubMed ID: 11772086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro antitumor activity of the novel marine agent, ecteinascidin-743 (ET-743, NSC-648766) against human tumors explanted from patients.
    Izbicka E; Lawrence R; Raymond E; Eckhardt G; Faircloth G; Jimeno J; Clark G; Von Hoff DD
    Ann Oncol; 1998 Sep; 9(9):981-7. PubMed ID: 9818072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Additional antitumor ecteinascidins from a Caribbean tunicate: crystal structures and activities in vivo.
    Sakai R; Rinehart KL; Guan Y; Wang AH
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11456-60. PubMed ID: 1454834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optically active diaryl tetrahydroisoquinoline derivatives.
    Naicker T; Govender T; Kruger HG; Maguire GE
    Acta Crystallogr C; 2011 Mar; 67(Pt 3):o100-3. PubMed ID: 21368406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total synthesis of ecteinascidin 743.
    Chen J; Chen X; Bois-Choussy M; Zhu J
    J Am Chem Soc; 2006 Jan; 128(1):87-9. PubMed ID: 16390134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New drugs from the sea.
    D'Incalci M; Simone M; Tavecchio M; Damia G; Garbi A; Erba E
    J Chemother; 2004 Nov; 16 Suppl 4():86-9. PubMed ID: 15688619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic studies on Et-743. Assembly of the pentacyclic core and a formal total synthesis.
    Fishlock D; Williams RM
    J Org Chem; 2008 Dec; 73(24):9594-600. PubMed ID: 18687003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. X-ray structure investigations of potential beta-blockers. II.6,7-Dimethoxy-1-phenyl-1,2,3,4-tetrahydroisoquinoline.
    Olszak TA; Stepień A; Grabowski MJ; Brzezińska E
    Acta Crystallogr C; 1996 Apr; 52 ( Pt 4)():1038-40. PubMed ID: 8624238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sea squirt assaults sarcomas.
    Burton A
    Lancet Oncol; 2002 Nov; 3(11):648. PubMed ID: 12424055
    [No Abstract]   [Full Text] [Related]  

  • 33. ET-743 (PharmaMar/NCI/Ortho Biotech).
    Verschraegen CF; Glover K
    Curr Opin Investig Drugs; 2001 Nov; 2(11):1631-8. PubMed ID: 11763168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total synthesis of ecteinascidin 743.
    Endo A; Yanagisawa A; Abe M; Tohma S; Kan T; Fukuyama T
    J Am Chem Soc; 2002 Jun; 124(23):6552-4. PubMed ID: 12047173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Development of marine-derived anti-cancer compounds].
    Taguchi T
    Gan To Kagaku Ryoho; 2003 May; 30(5):579-88. PubMed ID: 12795086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three tetrahydroisoquinolinedione derivatives.
    Subbiah Pandi A; Rajakannan V; Velmurugan D; Parvez M; Kim MJ; Senthilvelan A; Narasinga Rao S
    Acta Crystallogr C; 2002 Mar; 58(Pt 3):o164-7. PubMed ID: 11870315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemistry of ecteinascidins. Part 4: preparation of 2'-N-acyl ecteinascidin 770 derivatives with improved cytotoxicity profiles.
    Tsujimoto M; Lowtangkitcharoen W; Mori N; Pangkruang W; Putongking P; Suwanborirux K; Saito N
    Chem Pharm Bull (Tokyo); 2013; 61(10):1052-64. PubMed ID: 24088697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereospecific formal total synthesis of ecteinascidin 743.
    Zheng S; Chan C; Furuuchi T; Wright BJ; Zhou B; Guo J; Danishefsky SJ
    Angew Chem Int Ed Engl; 2006 Mar; 45(11):1754-9. PubMed ID: 16496274
    [No Abstract]   [Full Text] [Related]  

  • 39. Advances in the chemistry and pharmacology of ecteinascidins, a promising new class of anti-cancer agents.
    Manzanares I; Cuevas C; García-Nieto R; Marco E; Gago F
    Curr Med Chem Anticancer Agents; 2001 Nov; 1(3):257-76. PubMed ID: 12678757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthetic studies toward ecteinascidin 743.
    Chen X; Chen J; De Paolis M; Zhu J
    J Org Chem; 2005 May; 70(11):4397-408. PubMed ID: 15903318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.